3 results
Approved WMOCompleted
The central hypothesis of this project is that Aliskiren causes a substantial decrease in MSNA in hypertensive patients with CKD.
Approved WMOWill not start
In Part 1 of the study, a fixed dose of ABBV-3067 (potentiator) will be co-administered with ABBV-2222 (corrector) in a dose range-finding manner to enable a dose selection for ABBV-2222 for Part 2 and future combination studies. In addition, ABBV-…
Approved WMOPending
The aim of the current project is to evaluate the effect of a prosthetic foot, which can be individually optimized using human in the loop optimization, on metabolic cost of walking for transtibial amputees. We want to investigate both the effect of…